| 5-R01-EB028858-04 |
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC |
Andrew Tsourkas |
University of Pennsylvania |
| 5-R01-EB021155-08 |
Copper-mediated Radiofluorination: from Proof-of-Concept to Clinical Impact |
Peter Scott |
University of Michigan at Ann Arbor |
| 1-DP2-EB037187-01 |
Deep-tissue targeted molecular imaging with a palette of NIR-II emissive DNA-stabilized nanoclusters |
Stacy Copp |
University of California-Irvine |
| 5-R01-EB029429-04 |
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications |
Michael Evans |
University of California, San Francisco |
| 5-R03-EB033633-02 |
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization |
Jingjie Hu |
North Carolina State University Raleigh |
| 5-R21-EB032025-03 |
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2) |
Xuyi Yue |
Nemours Children'S Hospital, Delaware |
| 1-K99-EB035706-01A1 |
Development of Highly Multiplexed Raman Imaging Platform for Alzheimer’s Disease |
Olga Eremina |
University of Southern California |
| 5-R01-EB031821-04 |
Development of novel human Fab probes for PET imaging of macrophages |
Bernadette Marquez-Nostra |
University of Alabama at Birmingham |
| 1-R01-EB035631-01A1 |
Enabling systemic delivery of europium-containing contrast agents for magnetic resonance imaging |
Matthew Allen |
Wayne State University |
| 5-R01-EB032854-04 |
Engineering photostable fluorescent proteins and biosensors using transcriptomic mining and massive-throughput single-cell screening |
Francois St-Pierre |
Baylor College of Medicine |
